Discovery of MOMA-341, a potent and selective inhibitor of WRN Helicase

-MEDI First Time Disclosures: Breakthroughs on New Medicines

-Wednesday, August 20, 2025, 2 – 6 p.m.

-Washington Convention Center, Washington, D.C.

-Presenting Author: Dr. Meredeth McGowan, Head of Chemistry

-To learn more visit: https://cen.acs.org/pharmaceuticals/drug-development/Structures-13-drug-candidates-unveiled/103/web/2025/08